When we compared the levels of the three prohormones among patients with and without OSA at baseline, our results indicated that copeptin levels were significantly higher in OSA patients, but there was no significant difference in the levels of proADM (p = 0.069) or proANP (p = 0.086, Fig. 2). The gene discussed is AVP; the disease is obstructive sleep apnea syndrome.